Piśmiennictwo:

1. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 European Heart Journal 2008;29:2388-2442.

2. Lee DS, Stukel TA, Austin PC, et al. Improved Outcomes With Early Collaborative Care of Ambulatory Heart Failure Patients Discharged From the Emergency Department Circulation 2010;122:1806-1814.

3. van der Wal MHL, Dirk TJ, van Veldhuisen J. Non-compliance in patients with heart fail-ure; how can we manage it? Eur J Heart Fail 2005;7(1):5-17.

4. Tsuyuki RT, McKelvie RS, Arnold JMO, et al. Acute Precipitants of Congestive Heart Failure Exacerbations. Arch Intern Med 2001;161:2337-2342.

5. van der Wal MHL, Jaarsma1 T, Moser DK. Compliance in heart failure patients: the impor-tance of knowledge and beliefs. European Heart Journal 2006;27:434--440.

6. Gudmundsson K, Lyngå P, Karlsson H, et al. Midsummer Eve in Sweden: a natural fluid challenge in patients with heart failure. Eur J Heart Fail 2011;13(11):1172-7.

7. Scano G, Ambrosino N. Pathophysiology of dyspnea. Lung 2002;180(3):131-48.

8. Pang PS, Cleland JGF, Teerlink JR, et al. A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach European Heart Journal 2008;29:816-824.

9. Forrester JS, Diamond GA, Swan HJ. Correlative classification of clinical and hemody-namic function after acute myocardial infarction. Am J Cardiol 1977;39:137-145.

10. Yancy CW, Lopatin M, Stevenson LW, et al. Clinical Presentation, Management, and In-Hospital Outcomes of Patients Admitted With Acute Decompensated Heart Failure With Pre-served Systolic Function J Am Coll Cardiol 2006;47:76-84.

11. Hillege HL, Girbes ARJ, de KamPJ, et al. Renal Function, Neurohormonal Activation, and Survival in Patients With Chronic Heart Failure. Circulation 2000;102:203-210.

12. Klein L, Massie BM, Leimberger JD, et al. Admission or Changes in Renal Function Dur-ing Hospitalization for Worsening Heart Failure Predict Postdischarge Survival: Results From the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF). Circ Heart Fail 2008;1:25-33.

13. Maggioni AP, Dahlström U, Filippatos G, et al. EURObservational Research Programme: The Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail 2010;12(10):1076-1084.

Piśmiennictwo:

1. Meurer M. Toczeń. W: Dermatologia pod red. Braun-Falco. Lublin: Czelej, 2010;741-755.

2. Rahman A, Isenberg DA. Systemic lapus erythamatosus. N Engl J Med 2008;358:929-939.

3. Wozniacka A, McCauliffe DP. Optimal use of antimalarials in treating cutaneous lupus erythematosus. Am J Clin Dermatol 2005;6:1-11.